-
JPMorgan Resumes Coverage Of Eli Lilly: 'One Of The Best-Positioned Names In Our Group'
Wednesday, September 26, 2018 - 1:19pm | 395Shares of big-cap pharma names have been on a solid uptrend since the second-quarter earnings season in late July. Against this backdrop, Eli Lilly And Co (NYSE: LLY)'s prospects prompted a JPMorgan analyst to turn bullish on stock Wednesday. The Analyst Analyst Christ Schott resumed...